Canixa Life Sciences

Delhi, India Founded: 2007 • Age: 19 yrs
Pharmaceutical manufacturing and healthcare solutions focused on dermatological products in India.

About Canixa Life Sciences

Canixa Life Sciences is a Healthcare company based in Delhi (India) founded in 2007. It operates as a pharmaceutical manufacturing and healthcare solutions focused on dermatological products in India. The company has 892 employees. Its Indian entity Canixa Life Sciences Private Limited. reported revenue of β‚Ή202 Cr. Canixa Life Sciences offers products and services including Acne Care and Anti Allergic & Anti Itch. Its focus areas include Pharmaceuticals, Drug Manufacturing, Dermatological Products and Manufacturing.

Company details

Canixa Life Sciences is identified as a provider of healthcare solutions, with state-of-the-art manufacturing facilities and advanced formulation capabilities established to meet global demands for quality medicinal products. A commitment to supporting life is reflected through the creation of value-added healthcare solutions, including a wide range of dermatological products such as acne care and anti-fungal treatments. Investments in facilities and an extensive domestic network have been made to serve the medical fraternity effectively, ensuring products are developed and distributed in a humane manner.

  • Headquarters Delhi, India
  • Employees 892
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Canixa Life Sciences Private Limited.
  • Date of Incorporation 22 May, 2007
  • Jurisdiction Delhi, India
Key Metrics
  • Annual Revenue
    ₹202 Cr

    FY 2025 · +19% YoY

  • Net Profit
    ₹16.74 Cr

    FY 2025 · 8% margin

  • EBITDA
    ₹27.96 Cr

    FY 2025 · 14% margin

  • Employee Count
    892

Products & Services of Canixa Life Sciences

Canixa Life Sciences offers a comprehensive portfolio of products and services, including Acne Care and Anti Allergic & Anti Itch.

Acne Care
Skin Care Products

Acne care products are manufactured for treating skin conditions associated with acne.

Anti Allergic & Anti Itch
Allergy Treatments

Anti-allergic and anti-itch treatments are provided for managing allergic reactions and related symptoms.

Board of directors of Canixa Life Sciences Private Limited. (Canixa Life Sciences)

Canixa Life Sciences Private Limited. is the primary company behind Canixa Life Sciences. The board of Canixa Life Sciences Private Limited. currently have 2 directors; the longest-serving is Rupa Kanungo, appointed in 2007.

DirectorDesignationAppointedTenureEntity
Rupa Kanungo
DIN 02433776
Director22 May 200719 yrs 4 moCanixa Life Sciences Private Limited.
Pravat Kumar Kanungo
DIN 00895257
Director22 May 200719 yrs 4 moCanixa Life Sciences Private Limited.

Financials of Canixa Life Sciences

Figures of Canixa Life Sciences Private Limited., the primary company behind Canixa Life Sciences, for FY 2025. Revenue was ₹202 Cr (+19% year on year). Net profit was ₹16.74 Cr (8% margin). EBITDA was ₹27.96 Cr (14% margin). Revenue has grown at a compounded annual rate of +28% over three years and +18% over five years.

  • ₹202 CrRevenue · FY 2025 · +19% YoY
  • ₹16.74 CrNet profit · 8% margin
  • ₹27.96 CrEBITDA · 14% margin
  • ₹63.5 LakhPaid-up capital
  • 892Employees (provident fund records)
  • +28%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Canixa Life Sciences Private Limited. are on its company page.

Premium access

Detailed financial statements for Canixa Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Canixa Life Sciences

The website of Canixa Life Sciences (canixalife.com) receives about 3K visits a month.

  • Monthly visits
    3K

    ▼ 60% vs previous month

Top companies in Dermatology

10 companies that operate in the same segment as Canixa Life Sciences (Dermatology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
2002Newark, New Jersey, United StatesUSD 154.56 MUSD 234.04 M597
Diagnostic tests for cancer prognosis are provided.
2008Friendswood, Texas, United StatesUSD 61.97 MUSD 344.23 M761
Developer of drugs for treating dermatology diseases
1908Copenhagen, DenmarkUSD 560.38 M––
Skincare, beauty, and wellness services provided by VLCC across multiple countries.
1989Delhi, Delhi, India–––
Adhesive patch biopsies for skin cancer detection are provided.
1996San Diego, California, United StatesUSD 24.37 MUSD 15.3 M259
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608.25 M–197
Immunotherapeutic solutions for dermatological conditions are developed.
2016Westlake Village, California, United StatesUSD 94.5 MUSD 376.07 M342
Targeted small molecules are developed for oncology treatments.
2010Singapore, SingaporeUSD 100 M––
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured.
2014Pune, Maharashtra, IndiaUSD 25.97 MUSD 18.15 M508
Novel dermatologic therapies are developed for skin conditions.
2012Malvern, Pennsylvania, United StatesUSD 82 MUSD 7.83 M64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Canixa Life Sciences

Canixa Life Sciences was founded in 2007.

Canixa Life Sciences is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Canixa Life Sciences has 892 employees.

The primary company behind Canixa Life Sciences, Canixa Life Sciences Private Limited., reported revenue of β‚Ή202 Cr for FY 2025, up 19% year on year.

Canixa Life Sciences is identified as a provider of healthcare solutions, with state-of-the-art manufacturing facilities and advanced formulation capabilities established to meet global demands for quality medicinal products. A commitment to supporting life is reflected through the creation of value-added healthcare solutions, including a wide range of dermatological products such as acne care and anti-fungal treatments. Investments in facilities and an extensive domestic network have been made to serve the medical fraternity effectively, ensuring products are developed and distributed in a humane manner.

Canixa Life Sciences offers Acne Care and Anti Allergic & Anti Itch.

Canixa Life Sciences operates through Canixa Life Sciences Private Limited..

The legal entities of Canixa Life Sciences currently have 2 directors, including Rupa Kanungo, Pravat Kumar Kanungo.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available